Utah Medical Products (UTMD) makes specialty medical devices focused on labor and delivery, neonatal intensive care, and gynecology/urology. UTMD's largest single product is the Filshie Clip System, a titanium clip used for female sterilization (tubal ligation), which represented 26% of 2025 sales and holds a near-monopoly position among clip-based sterilization methods. Other key products include the INTRAN PLUS intrauterine pressure catheter, Gesco neonatal catheters purpose-built for premature infants, the LETZ electrosurgical system for pre-cancerous cervical lesions, and the Deltran disposable pressure transducer. Most of UTMD's devices are single-use consumables, so revenue tracks procedure volumes — births, NICU admissions, and gynecological procedures. UTMD manufactures almost entirely in-house in Utah and Ireland, and also produces components and devices for roughly 134 other U.S. medical device companies (OEM sales), which helps spread fixed overhead. Domestically, UTMD sells through a direct sales force and distributors; internationally (~41% of 2025 revenues), UTMD sells directly through subsidiaries in six countries and through ~200 independent distributors elsewhere. UTMD competes on clinical differentiation rather than price — its established brands carry decades of clinician trust — but faces a structural headwind as U.S. hospital purchasing shifts toward GPO-driven, lowest-unit-cost procurement, which erodes UTMD's pricing power.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →